We administered HCC s.c. tumors with SREBP-1 siRNA during Sorafenib or Sorafenib and Betulin combination treatments, and found that Betulin could not further control the growth of SREBP-1 knockdown tumors (Fig. 5a, b). The gene discussed is SREBF1; the disease is hepatocellular carcinoma.